COMPASS THERAPEUTICS INC (CMPX) Stock Price, Quote, News and Overview
NASDAQ:CMPX - Nasdaq - US20454B1044 - Common Stock - Currency: USD
CMPX Quote, Performance and Key Statistics
COMPASS THERAPEUTICS INC
NASDAQ:CMPX (1/23/2025, 11:51:02 AM)
2.965
+0.38 (+14.92%)
The current stock price of CMPX is 2.965 USD. In the past month the price increased by 88.32%. In the past year, price increased by 85.61%.
CMPX Latest News, Press Releases and Analysis
These stocks have an unusual volume in today's session
In today's session, these stocks are experiencing unusual volume.
Let's take a look at the stocks that are in motion in today's session.
What's going on in today's session
Compass Therapeutics Appoints Biopharmaceutical Industry Leader Barry Shin as Chief Financial Officer
BOSTON, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company...
Compass Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
BOSTON, Dec. 02, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company...
Compass Therapeutics to Participate in Upcoming Investor Events
BOSTON, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company...
Compass Therapeutics Reports 2024 Third Quarter Financial Results and Provides Corporate Update
Fully enrolled the Phase 2/3 trial of lead asset CTX-009 (DLL4 and VEGF-A bispecific antibody) in patients with biliary tract cancers (BTC); top-line data...
CMPX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.78 | 299.83B | ||
| AMGN | AMGEN INC | 14.25 | 147.25B | ||
| GILD | GILEAD SCIENCES INC | 20.88 | 115.28B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 846.14 | 111.13B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.06 | 75.19B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.41B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 34.92B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.15B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.48B | ||
| NTRA | NATERA INC | N/A | 22.65B | ||
| BIIB | BIOGEN INC | 8.77 | 20.86B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.30B |
Related screens
About CMPX
Company Profile
Compass Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of proprietary antibody therapeutics. The company is headquartered in Boston, Massachusetts and currently employs 32 full-time employees. The company went IPO on 2020-11-13. The firm is developing proprietary antibody-based therapeutics to treat multiple human diseases. Its pipeline of novel product candidates is designed to target multiple critical biological pathways required for an effective anti-tumor response. Its lead product candidate, CTX-009, is a bispecific antibody targeting Delta-like ligand 4 (DLL4), a ligand of Notch-1, and vascular endothelial growth factor A (VEGF-A). Its second program, CTX-471, is an agonistic antibody targeting a member of the tumor necrosis factor receptor superfamily member 9 (TNFRSF9), also known as CD-137, a co-stimulatory receptor which is mostly expressed on activated, but not on resting T-cells and NK cells. Its third program, CTX-8371, is a bispecific antibody targeting the programmed cell death protein-1 (PD-1), an inhibitory immune checkpoint receptor and its ligand PD-L1, two validated immune-oncology targets.
Company Info
COMPASS THERAPEUTICS INC
80 Guest Street
Boston MASSACHUSETTS US
Employees: 32
Company Website: https://www.compasstherapeutics.com/
Investor Relations: http://investors.compasstherapeutics.com
Phone: 16175008099
CMPX FAQ
What is the price of CMPX?
The current price of CMPX is 2.965 USD.
What is the symbol for COMPASS THERAPEUTICS INC?
The exchange symbol of COMPASS THERAPEUTICS INC is CMPX and it is listed on the Nasdaq exchange.
On which exchange is CMPX listed?
CMPX is listed on the Nasdaq exchange.
Is CMPX a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for CMPX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of CMPX.
Does CMPX pay dividends?
CMPX does not pay a dividend.
What is the Price/Earnings (PE) ratio of CMPX?
CMPX does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.37).
What is the Short Interest ratio of CMPX?
The outstanding short interest for CMPX is 2.26% of its float.
CMPX Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to CMPX. When comparing the yearly performance of all stocks, CMPX is one of the better performing stocks in the market, outperforming 94.52% of all stocks.
CMPX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CMPX. While CMPX has a great health rating, there are worries on its profitability.
CMPX Financial Highlights
Over the last trailing twelve months CMPX reported a non-GAAP Earnings per Share(EPS) of -0.37. The EPS increased by -12.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -32.02% | ||
| ROE | -34.51% | ||
| Debt/Equity | 0 |
CMPX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to CMPX. The Buy consensus is the average rating of analysts ratings from 14 analysts.